Final results of CORE-001: A phase-2, single arm study of cretostimogene grenadenorepvec in combination with pembrolizumab in patients with BCG-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ

被引：0
|
作者：
Li, Roger
Shah, Paras H.
Stewart, Tyler F.
Bivalacqua, Trinity
Lamm, Donald L.
Geynisman, Daniel M.
Meeks, Joshua J.
Uchio, Edward M.
Jacob, Joseph M.
Dickstein, Rian J.
Pearce, Shane
Burke, James M.
Steinberg, Gary D.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[2] Mayo Clin Rochester, Rochester, MN USA
[3] Univ Calif San Diego, La Jolla, CA USA
[4] Univ Penn, Perelman Sch Med, Div Urol, Philadelphia, PA USA
[5] BCG Oncol, Phoenix, AZ USA
[6] Fox Chase Canc Ctr, Philadelphia, PA USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL USA
[8] UCI Hlth, Orange, CA USA
[9] SUNY Upstate Med Univ, Syracuse, NY USA
[10] Chesapeake Urol, Hanover, MD USA
[11] Spokane Urol, Spokane, WA USA
[12] Billings Clin, Billings, MT USA
[13] Rush Univ, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4601
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial (Jun, 10.1038/s41591-024-03025-3, 2024)
    Li, Roger
    Shah, Paras H.
    Stewart, Tyler F.
    Nam, Jong Kil
    Bivalacqua, Trinity J.
    Lamm, Donald L.
    Uchio, Edward M.
    Geynisman, Daniel M.
    Jacob, Joseph M.
    Meeks, Joshua J.
    Dickstein, Rian
    Pearce, Shane M.
    Kang, Seok Ho
    Jung, Seung Il
    Kamat, Ashish M.
    Burke, James M.
    Keegan, Kirk A.
    Steinberg, Gary D.
    NATURE MEDICINE, 2024, 30 (08) : 2377 - 2377
  • [12] S1605: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer
    Singh, Parminder
    Catherine, Tangen
    Lerner, Seth P.
    McConkey, David
    Plets, Melissa
    Lucia, M. Scott
    Woods, Michael
    Bivalacqua, Trinity
    Kassouf, Wassim
    Bangs, Richard Carlton
    Thompson, Ian Murchie
    Black, Peter C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [13] A multicenter clinical trial of intravesical BCG in combination with ALT-803 in patients with BCG-unresponsive non-muscle invasive bladder cancer.
    Chamie, Karim
    Salmasi, Amirali
    Rosser, Charles Joel
    Rock, Amy
    Ferguson, Lydia
    Wong, Hing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [14] OUTCOMES OF PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: A SINGLE-INSTITUTION, REAL-WORLD SERIES
    Cook, Grayden
    Howard, Jeffrey
    Margulis, Vitaly
    Lotan, Yair
    JOURNAL OF UROLOGY, 2021, 206 : E123 - E124
  • [15] CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Rixe, Olivier
    Castonguay, Vincent
    Conter, Henry
    Chalas, Eva
    Desai, Pratibha
    Squillante, Christian
    MacDonald, Lisa A.
    Conlon, Rebekah
    Bramhecha, Yogesh
    Hirsch, Heather
    Graff, Jeremy R.
    Fiset, Stephan
    CANCER RESEARCH, 2022, 82 (12)
  • [16] AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS)
    Kulkarni, Girish
    Richards, Kyle
    Black, Peter C.
    Rendon, Ricardo
    Chin, Joseph
    Shore, Neal
    Jayram, Gautam
    Kramolowsky, Eugene
    Saltzstein, Daniel
    Agarwal, Piyush
    Belkoff, Laurence
    O'Donnell, Michael
    Kamat, Ashish M.
    Zlotta, Alexandre
    Jewett, Michael A. S.
    Lamm, Donald
    DeGruttola, Victor
    Mandel, Arkady
    Dumoulin-White, Roger J.
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2023, 209 : E871 - E871
  • [17] Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer
    Shen, Yijun
    Peng, Liangju
    Xu, Peihang
    Wang, Yanhao
    Wang, Xiang
    Yao Xudong
    Liu, Yushan
    Ye, Ding-Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [18] PHASE 2/3 CLINICAL RESULTS OF IL-15RAFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS) PATIENTS.
    Chamie, Karim
    Chang, Sam
    Gonzalgo, Mark
    Kramolowski, Eugene
    Reddy, Sandeep
    Soon-Shiong, Patrick
    Garner, Chad
    JOURNAL OF UROLOGY, 2021, 206 : E120 - E121
  • [19] A phase I/II study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients (pts) with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)
    Palou, J.
    Marcq, G.
    Steinberg, G.
    Toscone, C.
    Sullivan, J.
    Linback, T.
    Pruthi, R.
    Bryce, R.
    Brown, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S1165 - S1165
  • [20] CORE1: PHASE 2 SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Uchio, Edward M.
    Lamm, Donald
    Shah, Paras
    Kamat, Ashish M.
    Bivalacqua, Trinity J.
    Packiam, Vignesh
    Chisamore, Michael J.
    Mcadory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    JOURNAL OF UROLOGY, 2023, 209 : E408 - E409
12345